Molgramostim + sucralfate + hyaloronan is under clinical development by Reponex Pharmaceuticals and currently in Phase II for Venous Leg Ulcers (Crural Ulcer). According to GlobalData, Phase II drugs ...

Thousands of doses of omeprazole and sucralfate used to treat equine gastric ulcers and sent from the US to the UK have been seized – as owners are reminded that it is an offence to import such ...

Sucralfate (brand name: Carafate) is a medicine classified as a gastrointestinal (GI) protectant. It is used to treat and prevent ulcers (open sores) throughout the GI tract, including the ...

Sucralfate is used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers. Sucralfate Oral Suspension ...

This is the first Indian approval for this formulation by the USFDA. Sucralfate Oral Suspension is bioequivalent and therapeutically equivalent to the Reference Listed Drug, Carafate 1gm/10mL of ...

Constipation is the most common side effect of sucralfate (Carafate). A person can take steps to ease this side effect, such as remaining hydrated and taking stool softeners. Sucralfate (Carafate ...

For instance, the discovery of sucralfate's potential role in improving IVF success rates, as suggested by AI in a publication in "Nature Medicine," showcases the groundbreaking possibilities AI ...

The physical active ingredient in emoflon® called sucralfate works to form a mechanical barrier to promote wound healing emoflon® is applied around the anus after defecation, or a small amount ...

The affected Sucralfate Oral Suspension lot is No. 810300 with an expiration date of Oct. 31, 2023. The product can be identified by its product name, Sucralfate Oral Suspension. The affected ...